PT
Menu
Search
Sections
Home
News
Analysis
Features
Comment
Projects
Sectors
Clinical Trials
Drug Manufacturers
Therapy Area
Cardiovascular
Central Nervous System
Immunology
Infectious Disease
Oncology
Respiratory
Themes
Artificial Intelligence
Corporate Governance
Cloud
Cybersecurity
Environmental Sustainability
Internet of Things
Robotics
Social Responsibility
Covid-19
Insights
Deals
Jobs
Filings
Patents
Social Media
Companies
Company A-Z
Company Categories
Products & Services
Company Releases
White Papers
Videos
Buyer’s Guides
Partner Content
Pricing and Market Access
Events
Reports
Premium Insights
Excellence Awards
Magazine
GlobalData
About us
Advertise With Us
Contact Us
Our Marketing Solutions
GlobalData Reports
Visit GlobalData
From Our Partners
Transforming MedTech and Pharma using Software as a Medical Device (SaMD)
Accelerating Biopharmaceutical Innovation
Accelerating Clinical Trials
Precision medicine and digital health innovation for disease diagnosis, care and treatment
Enabling process intensification in biopharma manufacturing
Specialty drug launch strategy and operations
The next chapter of clinical trial services
Future Pharma Services
Putting quality first in the pharma supply chain
Enabling better biopharmaceutical manufacturing
Pharmaceutical Grade Silicone Manufacturer
Maximising molecule potential
News
Analysis
Sections
Features
Comment
Projects
Latest
Why is the healthcare industry hesitant to join the metaverse?
Illegal online pharmacies gain traction as regulators lag behind
After 2022 interest rate hikes spook investors, pharma M&A to resurge in late 2023
Sectors
Sections
Clinical Trials
Drug Manufacturers
Therapy Area
Latest
FDA accepts Iovance’s BLA for melanoma therapy lifileucel
Lexicon gets FDA approval for Inpefa to treat heart failure
FivepHusion collaborates with Treehill, Syneos for Deflexifol
Themes
Sections
Artificial Intelligence
Cloud
Corporate Governance
Cybersecurity
Environmental Sustainability
Internet of Things
Robotics
Social Responsibility
Covid-19
Latest
ICR and Royal Marsden NHS Foundation Trust open new integrated pathology unit
Sanofi deploys Veeva Systems’ solutions to improve quality management
Recursion plans $87.5m acquisitions to shore up AI drug discovery
Insights
Sections
Deals
Jobs
Filings
Patents
Social Media
Latest
Who’s saying what? Microbiome mentions in company filings of pharmaceutical industry decreased by 30% in Q1 2023
Who’s saying what? Blockchain mentions in company filings of pharmaceutical industry increased by 17% in Q1 2023
Who’s saying what? Orphan Designated Drugs mentions in company filings of pharmaceutical industry decreased by 18% in Q1 2023
Companies
Sections
Company A-Z
Company Categories
Products & Services
Company Releases
White Papers
Videos
Buyer’s Guides
Partner Content
Latest
Medicines adherence: Overcoming pharma’s biggest barrier to treatment success
Untangling the Complexities of Cell and Gene Therapy Clinical Trials: A Supply Chain Perspective
Untangling the Complexities of Cell and Gene Therapy Clinical Trials: A Supply Chain Perspective
Events
Reports
Premium Insights
PT
All articles by Tania Rodrigues
Tania Rodrigues
Pricing and Market Access
How to democratize access and prevent the next supermodel medicine
Pricing and Market Access
Dynamic reform in International Reference Pricing
Pricing and Market Access
Barricading the front door: A look at Colombia’s moves toward value-based pricing
Pricing and Market Access
International Reference Pricing expands reach in leading Latin American countries
Pricing and Market Access
International reference pricing: Love it or hate it, there is a good way and a bad way to do it
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
Subscribe
Pricing and Market Access
Hurdles encountered in transferability of health economic evidence to middle- and low-income countries
Pricing and Market Access
Two sides of the same coin: National health economic guidelines in Italy and Portugal
Pricing and Market Access
Proposed HTA agency AGNETS: The creation of a fourth hurdle in Argentina?
Pricing and Market Access
Through the comparative effectiveness research lens: US, European payers have a taste for real world trials
Pricing and Market Access
Inaction on hospital drug spending ruffles EC feathers as fresh political deadlock likely in Spain
View more
Most Popular
Who’s saying what? Virtual Care mentions in company filings of pharmaceutical industry decreased by 38% in Q1 2023
Who’s saying what? Regenerative Medicine mentions in company filings of pharmaceutical industry decreased by 24% in Q1 2023
Who’s saying what? Orphan Designated Drugs mentions in company filings of pharmaceutical industry decreased by 18% in Q1 2023